47
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The potential role of social support in reducing risk of opioid misuse following traumatic injury

, , , , , & show all
Received 03 Aug 2023, Accepted 02 Jan 2024, Published online: 25 Jan 2024

References

  • Agnoli A, Xing G, Tancredi DJ, Magnan E, Jerant A, Fenton JJ. 2021. Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids. JAMA. 326(5):411–419. doi: 10.1001/jama.2021.11013.
  • Alghnam S, Castillo R. 2017. Traumatic injuries and persistent opioid use in the USA: findings from a nationally representative survey. Inj Prev. 23(2):87–92. doi: 10.1136/injuryprev-2016-042059.
  • Allen KA, Kern ML, Rozek CS, McInereney D, Slavich GM. 2021. Belonging: a review of conceptual issues, an integrative framework, and directions for future research. Aust J Psychol. 73(1):87–102. doi: 10.1080/00049530.2021.1883409.
  • American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders. 5th ed. Washington D.C.: American Psychiatric Association. doi: 10.1176/appi.books.9780890425596.
  • Ashbaugh AR, Houle-Johnson S, Herbert C, El-Hage W, Brunet A. 2016. Psychometric validation of the English and French versions of the posttraumatic stress disorder checklist for DSM-5 (PCL-5). PLoS One. 11(10):e0161645. doi: 10.1371/journal.pone.0161645.
  • Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. 2015. The posttraumatic stress disorder checklist for DSM-5 (PCL-5): Development and initial psychometric evaluation. J Trauma Stress. 28(6):489–498. doi: 10.1002/jts.22059.
  • Bovin MJ, Marx BP, Weathers FW, Gallagher MW, Rodriguez P, Schnurr PP, Keane TM. 2016. Psychometric properties of the PTSD checklist for diagnostic and statistical manual of mental disorders-fifth edition (PCL-5) in veterans. Psychol Assess. 28(11):1379–1391. doi: 10.1037/pas0000254.
  • Brown R, Deyo B, Riley C, Quanbeck A, Glass JE, Turpin R, Hetzel S, Nicholas C, Cruz M, Agarwal S. 2017. Screening in Trauma for Opioid Misuse Prevention (STOMP): study protocol for the development of an opioid risk screening tool for victims of injury. Addict Sci Clin Pract. 12(1):28. doi: 10.1186/s13722-017-0097-6.
  • Brown RT, Deyo B, Nicholas C, Baltes A, Hetzel S, Tilhou A, Quanbeck A, Glass J, O'Rourke A, Agarwal S. 2022. Screening in Trauma for Opioid Misuse Prevention (STOMP): Results from a prospective cohort of victims of traumatic injury. Drug Alcohol Depend. 232:109286. doi: 10.1016/j.drugalcdep.2022.109286.
  • Butler SF, Budman SH, Fanciullo GJ, Jamison RN. 2010. Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy. Clin J Pain. 26(9):770–776. doi: 10.1097/AJP.0b013e3181f195ba.
  • Cance JD, Saavedra LM, Wondimu B, Scaglione NM, Hairgrove S, Graham PW. 2021. Examining the relationship between social connection and opioid misuse: a systematic review. Subst Use Misuse. 56(10):1493–1507. doi: 10.1080/10826084.2021.1936056.
  • Cavaiola AA, Fulmer BA, Stout D. 2015. The impact of social support and attachment style on quality of life and readiness to change in a sample of individuals receiving medication-assisted treatment for opioid dependence. Subst Abus. 36(2):183–191. doi: 10.1080/08897077.2015.1019662.
  • Center for Disease Control and Prevention [CDC]. 2019. Calculating total daily dose of opioids for safe dosage. https://www.cdc.gov/drugoverdose/pdf/calculating_total_daily_dose-a.pdf.
  • Center for Disease Control and Prevention [CDC]. 2022. Drug overdose overview. https://www.cdc.gov/drugoverdose/deaths/prescription/overview.html.
  • Chang CW, Chang KC, Griffiths MD, Chang CC, Lin CY, Pakpour AH. 2022. The mediating role of perceived social support in the relationship between perceived stigma and depression among individuals diagnosed with substance use disorders. J Psychiatr Ment Health Nurs. 29(2):307–316. doi: 10.1111/jpm.12794.
  • Chaudhary MA, Schoenfeld AJ, Harlow AF, Ranjit A, Scully R, Chowdhury R, Sharma M, Nitzschke S, Koehlmoos T, Haider AH. 2017. Incidence and predictors of opioid prescription at discharge after traumatic injury. JAMA Surg. 152(10):930–936. doi: 10.1001/jamasurg.2017.1685.
  • Chen CL, Jeffery MM, Krebs EE, Thiels CA, Schumacher MA, Schwartz AJ, Thombley R, Finlayson E, Rodriguez-Monguio R, Ward D, et al. 2020. Long-term trends in postoperative opioid prescribing, 1994 to 2014. JAAOS Glob Res Rev. 4(1):e19.00171. doi: 10.5435/JAAOSGlobal-D-19-00171.
  • Cohen S. 2008. Basic psychometrics for the ISEL-12. [Accessed October 28, 2023]. https://www.cmu.edu/dietrich/psychology/stress-immunity-disease-lab/scales/index.html.
  • Compton WM, Cottler LB, Dorsey KB, Spitznagel EL, Mager DE. 1996. Comparing assessments of DSM-IV substance dependence disorders using CIDI-SAM and SCAN. Drug Alcohol Depend. 41(3):179–187. doi: 10.1016/0376-8716(96)01249-5.
  • Cooper S, Campbell G, Larance B, Murnion B, Nielsen S. 2018. Perceived stigma and social support in treatment for pharmaceutical opioid dependence. Drug Alcohol Rev. 37(2):262–272. doi: 10.1111/dar.12601.
  • Cottler LB, Robins LN, Helzer JE. 1989. The reliability of the CIDI-SAM: a comprehensive substance abuse interview. Br J Addict. 84(7):801–814. doi: 10.1111/j.1360-0443.1989.tb03060.x.
  • Cragg A, Hau JP, Woo SA, Kitchen SA, Liu C, Doyle-Waters MM, Hohl CM. 2019. Risk factors for misuse of prescribed opioids: a systematic review and meta-analysis. Ann Emerg Med. 74(5):634–646. doi: 10.1016/j.annemergmed.2019.04.019.
  • Feingold D, Brill S, Goor-Aryeh I, Delayahu Y, Lev-Ran S. 2017. Misuse of prescription opioids among chronic pain patients suffering from anxiety: a cross-sectional analysis. Gen Hosp Psychiatry. 47:36–42. doi: 10.1016/j.genhosppsych.2017.04.006.
  • Feingold D, Brill S, Goor-Aryeh I, Delayahu Y, Lev-Ran S. 2018. The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: a cross-sectional study. J Affect Disord. 235:293–302. doi: 10.1016/j.jad.2018.04.058.
  • Hagerty BM, Lynch-Sauer J, Patusky KL, Bouwsema M, Collier P. 1992. Sense of belonging: a vital mental health concept. Arch Psychiatr Nurs. 6(3):172–177. doi: 10.1016/0883-9417(92)90028-h.
  • Hakulinen C, Pulkki-Råback L, Jokela M, E Ferrie J, Aalto AM, Virtanen M, Kivimäki M, Vahtera J, Elovainio M. 2016. Structural and functional aspects of social support as predictors of mental and physical health trajectories: Whitehall II cohort study. J Epidemiol Community Health. 70(7):710–715. doi: 10.1136/jech-2015-206165.
  • Harandi TF, Taghinasab MM, Nayeri TD. 2017. The correlation of social support with mental health: A meta-analysis. Electron Phys. 9(9):5212–5222. doi: 10.19082/5212.
  • Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. 2009. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 42(2):377–381. doi: 10.1016/j.jbi.2008.08.010.
  • Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, REDCap Consortium, et al. 2019. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 95:103208. doi: 10.1016/j.jbi.2019.103208.
  • IBM Corp. 2021. IBM SPSS Statistics for Windows, Version 28.0. Armonk, NY: IBM Corp.
  • Jalali MS, Botticelli M, Hwang RC, Koh HK, McHugh RK. 2020. The opioid crisis: a contextual, social-ecological framework. Health Res Policy Sys. 18(1):87. doi: 10.1186/s12961-020-00596-8.
  • Kennedy-Hendricks A, Gielen A, McDonald E, McGinty EE, Shields W, Barry CL. 2016. Medication sharing, storage, and disposal practices for opioid medications among US adults. JAMA Intern Med. 176(7):1027–1029. doi: 10.1001/jamainternmed.2016.2543.
  • Kim Y, Dykema J, Stevenson J, Black P, Moberg DP. 2019. Straightlining: overview of measurement, comparison of indicators, and effects in mail–web mixed-mode surveys. Soc Sci Comput Rev. 37(2):214–233. doi: 10.1177/0894439317752406.
  • Kroenke K, Spitzer RL, Williams JB. 2001. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
  • Kroenke K, Wu J, Yu Z, Bair MJ, Kean J, Stump T, Monahan PO. 2016. Patient health questionnaire anxiety and depression scale: initial validation in three clinical trials. Psychosom Med. 78(6):716–727. doi: 10.1097/PSY.0000000000000322.
  • Kuo YF, Baillargeon J, Raji MA. 2021. Overdose deaths from nonprescribed prescription opioids, heroin, and other synthetic opioids in Medicare beneficiaries. J Subst Abuse Treat. 124:108282. doi: 10.1016/j.jsat.2021.108282.
  • Merz EL, Roesch SC, Malcarne VL, Penedo FJ, Llabre MM, Weitzman OB, Navas-Nacher EL, Perreira KM, Gonzalez F, Ponguta LA, et al. 2014. Validation of interpersonal support evaluation list-12 (ISEL-12) scores among English- and Spanish-speaking Hispanics/Latinos from the HCHS/SOL Sociocultural Ancillary Study. Psychol Assess. 26(2):384–394. doi: 10.1037/a0035248.
  • McDonough MH, Jose PE, Stuart J. 2016. Bi-directional effects of peer relationships and adolescent substance use: A longitudinal study. J Youth Adolesc. 45(8):1652–1663. doi: 10.1007/s10964-015-0355-4.
  • Nalven T, Spillane NS, Schick MR. 2020. Risk and protective factors for opioid misuse in American Indian adolescents. Drug Alcohol Depend. 206:107736. doi: 10.1016/j.drugalcdep.2019.107736.
  • Nicholson HL, Vincent J. 2019. Gender differences in prescription opioid misuse among U.S. black adults. Subst Use Misuse. 54(4):639–650. doi: 10.1080/10826084.2018.1531427.
  • Orlas CP, Herrera-Escobar JP, Hau KM, Velmahos A, Patel N, Sanchez S, Kaafarani HMA, Salim A, Nehra D. 2021. Perceived social support is strongly associated with recovery after injury. J Trauma Acute Care Surg. 91(3):552–558. doi: 10.1097/TA.0000000000003230.
  • Payne TJ, Andrew M, Butler KR, Wyatt SB, Dubbert PM, Mosley TH. 2012. Psychometric evaluation of the interpersonal support evaluation list–short form in the ARIC study cohort. SAGE Open. 2(3):215824401246192. doi: 10.1177/2158244012461923.
  • Rogers AH, Zvolensky MJ, Ditre JW, Buckner JD, Asmundson GJG. 2021. Association of opioid misuse with anxiety and depression: A systematic review of the literature. Clin Psychol Rev. 84:101978. doi: 10.1016/j.cpr.2021.101978.
  • Roohafza HR, Afshar H, Keshteli AH, Mohammadi N, Feizi A, Taslimi M, Adibi P. 2014. What’s the role of perceived social support and coping styles in depression and anxiety? J Res Med Sci. 19(10):944–949.
  • Schepis TS, Klare DL, Ford JA, McCabe SE. 2020. Prescription drug misuse: taking a lifespan perspective. Subst Abuse. 14:1178221820909352. doi: 10.1177/1178221820909352.
  • Spitzer RL, Kroenke K, Williams JB, Löwe B. 2006. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 166(10):1092–1097. doi: 10.1001/archinte.166.10.1092.
  • Stevens E, Jason LA, Ram D, Light J. 2015. Investigating social support and network relationships in substance use disorder recovery. Subst Abus. 36(4):396–399. doi: 10.1080/08897077.2014.965870.
  • Tilhou AS, Glass JE, Hetzel SJ, Shana OE, Borza T, Baltes A, Deyo BMF, Agarwal S, O'Rourke A, Brown RT. 2022. Association between spine injury and opioid misuse in a prospective cohort of Level I trauma patients. OTA Int. 5(3):e205.1–6. doi: 10.1097/OI9.0000000000000205.
  • Webster LR. 2017. Risk factors for opioid-use disorder and overdose. Anesth Analg. 125(5):1741–1748. doi: 10.1213/ANE.0000000000002496.
  • Wesselmann ED, Parris L. 2021. Exploring the links between social exclusion and substance use, misuse, and addiction. Front Psychol. 12:674743. doi: 10.3389/fpsyg.2021.674743.
  • Zini MLL, Banfi G. 2021. A narrative literature review of bias in collecting patient reported outcomes measures (PROMs). Int J Environ Res Public Health. 18(23):12445. doi: 10.3390/ijerph182312445.
  • Zullo AR, Danko KJ, Moyo P, Adam GP, Riester M, Kimmel HJ, Panagiotou OA, Beaudoin FL, Carr D, Balk EM. 2020. Prevention, diagnosis, and management of opioids, opioid misuse, and opioid use disorder in older adults. Rockville, MD: Agency for Healthcare Research and Quality (US).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.